Monday: March 25, 2019
Opening Lecture
HIV, STI, and HCV, Oh My!
Marty Soehnlen, PhD
Presentation
Conference Primer
Current Epidemiology of HIV in America
John Brooks, MD
Presentation
Overview of HIV Testing Practices and Technology
S. Michele Owen, PhD
Presentation
Hepatitis C Virus Diagnostic Methodologies
Saleem Kamili, PhD
Presentation
HIV is an STI—Let’s Not Forget the Other Curable STI that Play a Role in HIV Prevention & Control
Barbara Van der Pol, PhD
Presentation
Update from FDA on Reclassification of HCV and HIV Diagnostic Tests from Class III to Class II
Julia Lathrop, PhD
Presentation
Tuesday: March 26,2019
Session A: Implementation and Impact of the HIV Laboratory Algorithm in the US
Shared Service Success: Six Years of HIV Nucleic Acid Testing for US Public Health Laboratories
Anne Gaynor, PhD,
Presentation
Identifying Acute HIV Infection, National HIV Surveillance System
Laurie Linley, MPH
Presentation
Trends in Diagnosis of Acute HIV Infection, New York City, 2010-2017
Emily Westheimer, MS
Presentation
An Improved 4th Generation Prototype Assay for Earlier Detection of HIV Acute Infection
Xiaoxing Qiu, PhD
Presentation
Improved HIV Diagnostic Report Turnaround Time Using the HIV Algorithm Workflow System
Erin Goecker, MS
Presentation
Routine HIV Testing Results in 6 U.S. Clinical Laboratories Using the CDC/APHL Laboratory HIV Testing Algorithm with Geenius HIV 1/2 Supplemental Assay
Laura Wesolowski, PhD
Presentation
Session B: Updates on HIV-2 Testing in the US
Avioq VioOne HIV Profile Supplemental Assay for confirmation and differentiation of HIV-1 and HIV-2 antibodies
Michael Cronin, MS
Presentation
Differentiation between HIV-2 Single-Infection and HIV-1/-2 Dual- Infection by the Bio-Rad GeeniusTM HIV 1/2 Supplemental Assay
Ming Chang, PhD, MB(ASCP)
Presentation
An Evaluation of Qualitative HIV-2 RNA Referral Testing
Linda Styer, PhD
Presentation
Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals
Linda Styer, PhD
Presentation
HIV-1/2 Differentiation in the U.S. HIV Laboratory Testing Algorithm: High Burden, Low Yield
Anne Peruski, PhD
Presentation
Discussion Panel: Strategies and Stories of Improved Partnerships Between Laboratory and Programs
Discussants:
Christopher Finch, BS
Nicolas Epie, PhD
Monica Parker, PhD
Kristie Schwarzkopf, BS
Presentation
Session C: Roles for Quantitative and Qualitative Nucleic Acid Tests in Diagnostic Algorithms (Part 1)
Performance evaluation of a point-of-care whole blood viral load test (SAMBA II HIV-1 Semi-Q Whole Blood) to optimize HIV treatment
Gary Brook, MD FRCP DTM&H
Cross-clade HIV-1 DNA detection from frozen whole blood using droplet digital PCR
Erin Goecker, MS
Presentation
Determinants of DNA PCR uptake among HIV exposed infants attending clinic within a HIV program in Kenya; A retrospective cohort study
Douglas Gaitho, M.B.Ch.B
Presentation
Performance Characteristics of GeneXpert and Alere Q Point of Care Technologies for HIV Early Infant Diagnosis in Kenya
Dorcus Abuya, MSc
Presentation
Session D: Roles for Quantitative and Qualitative Nucleic Acid Tests in Diagnostic Algorithms (Part 2)
Performance of an Alternative HIV Diagnostic Algorithm Including HIV-1 RNA Viral Load Compared to the CDC/APHL Laboratory Diagnostic Algorithm
Marc Pitasi, MPH
Presentation
Could HIV-1 RNA be an Option as the Second Step in the HIV Diagnostic Algorithm?
Silvina Masciotra, MSc
Presentation
Evaluation of Contamination Risk during Processing by the cobas® e 602 Serology Module Prior to HIV/HCV Viral Load Testing on the cobas® 6800 System
Pedro Rodriguez, PhD
Presentation
SAMBA: A Point-of-Care NAT for Detection of HIV Viremia
Lauren Violette, MPH
Discussion Panel: Opportunities Created by Diagnostic HCV and HIV NAT
Discussants:
Ann Winters, MD
Ana María Cárdenas, Ph.D., D(ABMM)
Joanne Stekler, MD, MPH
Presentation
WEDNESDAY, MARCH 27 2019
Session E: Integrated Testing for Multiple Pathogens
A Newer Generation of Rapid Assays: Detection of HIV and Syphilis Simultaneously
Niel Constantine, PhD
Side by Side Comparison: DPP HIV Syphilis Assay System vs. Syphilis Health Check
Eugene Martin, PhD
Enhancing the Routine Screening Infrastructure to Address a Syphilis Epidemic in Miami-Dade County
Alejandro Larios
North Carolina Test, Link, Cure: Collaborating to Address Hepatitis C in At-Risk Populations
Rebecca Pelc, PhD
Discussion Panel: Integrated Testing and Screening—From Primary Care to Public Health
Discussants:
Vaneet Arora, MD
Lesley Miller, MD
Liisa Randall, PhD
Presentation
Session F: Novel Testing Strategies for STI and HCV
The Use of a Syphilis Rapid Test with Specimens from an HIV Cluster Investigation in rural West Virginia
Lara Pereira, PhD
Presentation
Performance of the Reverse Algorithm Using the Abbott Architect Syphilis TP and its Role in a “Blended” Diagnostic Application in Florida’s Public Health Testing Population
Yolanda Totten, BS, MT (AAB)
Presentation
Evaluation of the Point-of-Care SAMBA II HCV Qualitative Whole Blood Test
Sonny Michael Assennato, MSc
Session G: Testing Outside the Laboratory
Rapid Testing Algorithm Performance in a Low Prevalence Environment
Eugene Martin, PhD
Presentation
Failure of the Alere Determine 4th Generation Point of Care Test to Detect an Acute HIV-1 Infection
Carol Loring, MS
Presentation
Evaluation of Different Rapid Testing Algorithms for Venue-based Anonymous HIV Testing among Men Who Have Sex with Men (MSM), National HIV Behavioral Surveillance (NHBS), 2017
Shamaya Whitby, MS
Presentation
Quickie in the Club—You Are 7 Minutes from Your Status
Jonathon Antle
Presentation
Performance, Usability and Acceptance of the Blood-Based INSTI HIV Self-Test in High and low HIV Prevalent Populations
Rick Galli, BSc
Presentation
Implementation Challenges of App-Requested HIV and STI Home Test Kits Among Men Who Have Sex with Men
Ryan Zahn, MSPH
Presentation
Discussion Panel: Self-Testing and Self-Collection for HIV and STIs
Discussants:
Charlotte Gaydos, DrPH
Benjamin Tsoi, MD, MPH
Pollyanna Ch´avez, PhD
Presentation
THURSDAY, MARCH 28 2019
Session H: Expanding Access to Testing Through the Use of Dried Blood Spots
The Feasibility of Modified HIV and Antiretroviral Drug Testing Using Self-collected Dried Blood Spots from Men Who Have Sex with Men
Wei Luo, MS
Presentation
Comparison of the Geenius™ HIV-1/2 Supplemental Assay and HIV-1 Western Blot for HIV Rapid Test Confirmation from Dried Blood Spots
Tim Sullivan, BS
Presentation
Quantification of HIV-1 RNA in Dried Blood Spots (DBS) Using the Abbott RealTime HIV-1 DBS assay
Ming Chang, PhD, MB(ASCP)
Empowerment of Canada’s Indigenous Communities to Improve Access to HIV and HCV Testing using Dried Blood Spots
John Kim
Presentation
Session I: Emerging Testing Issues
Multiplex Screening Kit for Routine Monitoring of HIV Suppression and Drug Resistance
Jonathan Lipscomb, MPH
Presentation
Implementation of Next Generation Sequencing Technology for HIV Resistance Determination and Genotyping
Marie-Claire Rowlinson, PhD
Presentation
Independent assessment of the Sedia Asanté™ HIV-1 Rapid Recency® Assay
Eduard Grebe, PhD
Presentation
Performance of HIV Ag/Ab Assays on Samples from Individuals Initiating Antiretroviral Therapy During Acute HIV Infection
Mark Manak, PhD
Presentation
Case Study of the Value of Historical Archives for Diagnostic Advancements
Gary Murphy, PhD
Presentation